Company: IXHL
Filing Date: 2025-04-17
Form Type: PRER14A
Source: 0001213900-25-033013
Chunk: 12

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-17
Form: PRER14A
Chunk 12
---
 not attend the Special Meeting in order to vote.

Householding of Annual Disclosure Documents

Some brokers or other nominee record holders may
be sending you a single set of our proxy materials if multiple Incannex stockholders live in your household. This practice, which has
been approved by the Securities and Exchange Commission (the “SEC”), is called “householding.” Once you receive
notice from your broker or other nominee record holder that it will be “householding” our proxy materials, the practice will
continue until you are otherwise notified or until you notify them that you no longer want to participate in the practice. Stockholders
who participate in householding will continue to have access to and utilize separate proxy voting instructions.

We will promptly deliver a separate copy of our
proxy materials to you if you write or call our Secretary at: Incannex Healthcare Inc., Suite 105, 8 Century Circuit, Norwest, NSW 2153
Australia or +61 409 840 786. If you want to receive your own set of our proxy materials in the future or, if you share an address with
another stockholder and together both of you would like to receive only a single set of proxy materials, you should contact your broker
or other nominee record holder directly or you may contact us at the above address and phone number.

Electronic Delivery of Company Stockholder Communications

Most stockholders can elect to view or receive
copies of future proxy materials over the Internet instead of receiving paper copies in the mail.

You can choose this option and save us the cost
of producing and mailing these documents by:

| ● | following the instructions provided on your proxy card; or |

| ● | following the instructions provided when you vote over the Internet. |

<div align='center'>7

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
AND MANAGEMENT</div>

The following table sets forth information known
to us regarding the beneficial ownership of our common stock as of April 9, 2025 by:

| ● | each person known to us to be the beneficial owner of more than 
 5% of our outstanding common stock;                             |

| ● | each of our named executive officers and directors; and |

| ● | all of our current executive officers and directors as a group. |

The beneficial ownership of our common stock presented
below is based on 27,546,753 shares of our common stock issued and outstanding as of April 9, 2025.

Beneficial ownership is determined according to